BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20855282)

  • 1. [Response to metoprolol succinate sustained-release tablets in correlation to pulse pressure, serum vascular endothelial growth factor and C-reactive protein in elderly hypertensive patients with chronic heart failure].
    Zhang ZW; Lin ZP
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2171-4. PubMed ID: 20855282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
    Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
    Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience.
    Batisky DL; Sorof JM; Sugg J; Llewellyn M; Klibaner M; Hainer JW; Portman RJ; Falkner B;
    J Pediatr; 2007 Feb; 150(2):134-9, 139.e1. PubMed ID: 17236889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative trial of ordinary metoprolol tablets and metoprolol sustained-release tablets in hypertensive patients at rest and on exercise.
    Witchitz S; Moisson P; Kolsky H
    Pharmatherapeutica; 1984; 3(8):566-72. PubMed ID: 6366811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.
    Aquilante CL; Terra SG; Schofield RS; Pauly DF; Hatton PS; Binkley PF; Johnson JA
    J Card Fail; 2006 Apr; 12(3):171-6. PubMed ID: 16624680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
    Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
    Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of severe chronic heart failure patients with normal blood B-type natriuretic peptide].
    Yang ZY; Li KL; Wang Q; Wang RX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):979-82. PubMed ID: 21215225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives.
    Conen D; Dieterle T; Utech K; Rimner M; Martina B
    Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
    Yu WP; Lou M; Deng B; Song HM; Wang HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload.
    Mottram PM; Haluska BA; Marwick TH
    Am Heart J; 2004 Aug; 148(2):365-70. PubMed ID: 15309010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure].
    Zhang YH; Lü R; Zhao XY; Kang LM; Yang YJ; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):126-9. PubMed ID: 19719987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension.
    King DE; Egan BM; Mainous AG; Geesey ME
    J Clin Hypertens (Greenwich); 2006 Apr; 8(4):257-60. PubMed ID: 16596028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.